Article Details

Pfizer Begins Patient Dosing in Phase 3 Prostate Cancer Drug Trial

Retrieved on: 2021-06-24 11:37:30

Tags for this article:

Click the tags to see associated articles and topics

Pfizer Begins Patient Dosing in Phase 3 Prostate Cancer Drug Trial. View article details on hiswai:

Excerpt

Chief Development Officer, Oncology, Pfizer Global Product Development, Chris Boshoff, said, “By combining enzalutamide, which has a proven clinical ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up